Nascent Biotech, Inc. filed its 10-K/A on Jul 03, 2023 for the period ending Mar 31, 2023. In this report its auditor, Fruci & Associates II, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0998 USD | 0.00% | -0.10% | -42.28% |
1st Jan change | Capi. | |
---|---|---|
-42.28% | 17.03M | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- NBIO Stock
- News Nascent Biotech, Inc.
- Nascent Biotech, Inc. Auditor Raises 'Going Concern' Doubt